Experimental Antibiotic Targets Dangerous Bacteria While Sparing Helpful Gut Microbes
University of Illinois Urbana-Champaign researchers developed lolamicin, an experimental antibiotic that targets a protein transport system in Gram-negative bacteria. In mouse studies it fought resistant infections while largely sparing gut…

